Naledi S.

MU at R823.03 is still riding the AI chip cycle, but memory oversupply is a real risk if demand softens. The dividend yield is thin and capex is chunky, so you're really betting on earnings growth to stick, not income.

sorry if this is obvious but with platinum prices staying weak and load shedding eating into output, how is ssw supposed to compete with someone like impala or northam right now? i get the palladium mix helps but the balance sheet looks stretched to me, 35.88 feels like a value trap unless there's a real recovery in automotive demand soon.

4.18 now, that's nice movement

sorry if this is obvious but when sextant mentions the all-in sustaining costs coming down, is that the main reason HAR's outperforming? I'm trying to understand if it's just rand weakness or if there's actually something better happening operationally. Still learning how to read miners properly.

Back to 11.22, shame.

1.28 now, that's what I like to see

can someone explain what halving does to the price, still learning here

@easy_money_sa bit ambitious but I like the energy haha

Come on ARI, show us what you've got!

still learning, but why does everyone say azure is the future? what makes it different from aws?

Wall at 166 didnt take long to crumble. Someone knew something.

sorry if this is obvious but i keep reading that mtn's debt is the real problem, not the revenue side. the dividend looks nice on paper at 204.97 but if they're spending everything on capex just to stay competitive with vodacom and keep the network decent, where's the cash actually coming from to pay down that balance sheet. am i missing something or is this just a yield trap situation.

sorry if this is obvious, still learning, but I'm worried about the capex they need just to keep the network going while load-shedding makes everything harder. The dividend is nice but if debt stays this high and revenue gets squeezed, that yield might not look so decent in a year. Are they actually investing enough to compete or just trying to keep shareholders happy while treading water?

DCCUS2 at R1671.85 is basically a proxy for USD strength and interest rate plays rather than equity selection, so you're really betting on currency and global bond markets rather than underlying company fundamentals. The yield is decent if you believe the rand stays weak, but the

@rawssy_links yep, the naira keeps hurting them hey

@jse_tttrading ja, the rand thing makes sense actually

@cape_steel yeah that's what worries me too, the refining squeeze. dividend's nice but if cash flow tightens it gets real quick

been reading up on abbv's immunology business and it seems like a decent moat, but i'm worried about the patent cliff coming up. someone told me humira's losing exclusivity soon which is like half their revenue, eish. is that priced in already at 250.94 or am i missing something.

sorry if this is obvious, still learning, but has anyone looked at where ARI's platinum realizations are headed? with load-shedding grinding on and capex still eating cash, feels like the dividend might be under pressure if commodity prices don't recover soon. am i reading the fundamentals wrong or is this more of a wait-and-see on energy costs improving?

@jozi_janet ja that makes sense, cloud margins are the real story here